Text Size
82 studies found for:    Open Studies | "Peritoneal Dialysis"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Not yet recruiting The Effect of Intra-abdominal t-PA and and DNase on Peritonitis in Peritoneal Dialysis Patients
Conditions: Peritoneal Dialysis;   Peritoneal Dialysis, Continuous Ambulatory
Interventions: Drug: Tissue Plasminogen Activator (tPA);   Drug: recombinant deoxyribonuclease (DNase)
2 Recruiting Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis
Conditions: End Stage Renal Disease;   Peritoneal Dialysis
Intervention:
3 Unknown † Simvastatin Effect on End Stage Renal Failure Patients Treated by Peritoneal Dialysis
Conditions: Renal Failure, End Stage;   Peritoneal Dialysis
Intervention: Drug: Simvastatin
4 Recruiting The Effects Nutrition Status and Body Composition On Peritoneal Dialysis Outcome
Conditions: Peritoneal Dialysis;   Wasting and Malnutrition
Intervention:
5 Unknown † Anti-Oxidant Effect on Peritoneal Membrane in Peritoneal Dialysis (PD) Patients
Conditions: End-Stage Kidney Disease;   Peritoneal Dialysis
Intervention: Drug: N-acetylcysteine
6 Unknown † Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
Condition: Peritoneal Dialysis
Intervention: Drug: alendronate (Fosamax)
7 Unknown † Effect of N-Acetylcysteine on Peritoneal Membrane Function in Chronic Peritoneal Dialysis Patients
Conditions: ESRD;   Peritoneal Dialysis
Intervention: Drug: Oral N-Acetylcysteine 1200 mg x 2/day for 4 weeks.
8 Unknown † Bioimpedance as a Tool for Fluid Management in Peritoneal Dialysis (PD) Patients
Conditions: Fluid Status;   Peritoneal Dialysis
Intervention:
9 Recruiting Effect of Bio-impedance Analysis and Vitamin D vs Usual Care on Left Ventricular Mass in Peritoneal Dialysis Patients: A Randomized Controlled Trial (FLUID Study)
Condition: Peritoneal Dialysis
Interventions: Drug: Bioimpedance and Vitamin D;   Drug: Usual care and placebo;   Drug: Usual care and Vitamin D;   Device: Bioimpedance and Placebo
10 Recruiting Prevention of Peritonitis in Peritoneal Dialysis
Conditions: Kidney Failure, Chronic;   Peritoneal Dialysis-associated Peritonitis;   Dialysis Capd Infection
Intervention: Behavioral: Follow-up of PD patients´ theoretical and practical skills
11 Unknown † Study to Evaluate the Protective Effect of α-Keto Acid With Low-Protein Diet (LPD) on Renal Function (RRF) in Peritoneal Dialysis (PD) Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Dietary Supplement: α-Keto Acid with low protein diet;   Dietary Supplement: Normal protein diet
12 Recruiting Diurnal Variation of Mineral Metabolism and Protein Fermentation Metabolites in Peritoneal Dialysis Patients and Healthy Volunteers
Condition: Peritoneal Dialysis
Intervention:
13 Recruiting Comparison of Outcomes Between Hemodialysis and Peritoneal Dialysis Patients in a Multi-Ethnic Asian Population
Conditions: Stage 5 Chronic Kidney Disease;   Hemodialysis;   Peritoneal Dialysis
Intervention:
14 Unknown † The Effect of Enalapril and Losartan on Peritoneal Membrane in Continuous Ambulatory Peritoneal Dialysis Patients
Condition: Continuous Ambulatory Peritoneal Dialysis
Interventions: Drug: Enalapril;   Drug: Enalapril plus Losartan;   Drug: Placebo
15 Recruiting Natural History of Mineral Metabolism Parameters and Protein-bound Toxins in Incident Peritoneal Dialysis Patients
Condition: Complication of Peritoneal Dialysis
Intervention:
16 Not yet recruiting Bacteria Endotoxin in Peritoneal Dialysis Effluent as a Predictor of Relapsing, Recurrent, and Repeat Peritonitis
Condition: Peritoneal Dialysis Associated Peritonitis
Intervention: Other: endotoxin assay in peritoneal dialysis effluent
17 Unknown † The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis
Conditions: Peritoneal Dialysis;   Hemodialysis
Intervention:
18 Recruiting A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia
Conditions: Peritoneal Dialysis;   Hyperphosphatemia
Intervention: Drug: PA21
19 Unknown † Relationship of Peritoneal Solute Transport Rate With VEGF in Children Undergoing Peritoneal Dialysis
Condition: Peritoneal Dialysis
Intervention:
20 Not yet recruiting Topical Gentamicin Cream Versus Alternating Gentamicin and Mupirocin Cream in Peritoneal Dialysis
Conditions: Rate of Exit Site Infection;   Rate of Atypical Mycobacterial Infection;   Rate of Peritoneal Dialysis
Interventions: Drug: gentamicin;   Drug: gentamicin cream alternating with mupirocin cream
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years